Electrochemical behavior of an antiviral drug acyclovir at fullerene-C60-modified glassy carbon electrode

Bioelectrochemistry

Volumn 88, Issue , 2012, Pages 76-83

  Shetti, Nagaraj P ^a   Malode, Shweta J ^b   Nandibewoor, Sharanappa T ^b  

^a KLE Society's KLE Institute of Technology   (India)

^b KARNATAK UNIVERSITY   (India)

Author keywords

Acyclovir; Drug analysis; Fullerene C60 modified glassy carbon electrode; Oxidation; Voltammetry

Indexed keywords

ACYCLOVIR; ANODIC PEAK POTENTIAL; ANODIC PEAKS; ANTI-VIRAL DRUGS; BIOLOGICAL FLUIDS; BLOOD PLASMA; CONCENTRATION RANGES; DETECTION LIMITS; DIFFERENTIAL PULSE VOLTAMMETRY; DRUG ANALYSIS; ELECTROCATALYTIC ACTIVITY; ELECTROCATALYTIC BEHAVIOR; ELECTROCHEMICAL BEHAVIORS; HETEROGENEOUS RATE CONSTANT; IRREVERSIBLE OXIDATION; MODIFIED GLASSY CARBON ELECTRODE; OPTIMIZED CONDITIONS; PHARMACEUTICAL FORMULATION; PHOSPHATE BUFFERS; REAL SAMPLES; SENSITIVE DETECTION; VOLTAMMETRIC;

BODY FLUIDS; ELECTROCHEMICAL OXIDATION; FULLERENES; GLASS MEMBRANE ELECTRODES; OXIDATION; RATE CONSTANTS; VIRUSES; VOLTAMMETRY;

DRUG PRODUCTS;

ACICLOVIR; CARBON; FULLERENE;

ARTICLE; BLOOD SAMPLING; BODY FLUID; CATALYSIS; CYCLIC POTENTIOMETRY; DIFFERENTIAL PULSE VOLTAMMETRY; DRUG BLOOD LEVEL; DRUG OXIDATION; DRUG URINE LEVEL; ELECTROCHEMISTRY; ELECTRODE; GLASSY CARBON ELECTRODE; HUMAN; QUALITY CONTROL; URINALYSIS;

ACYCLOVIR; ANTIVIRAL AGENTS; CALIBRATION; CARBON; ELECTROCHEMISTRY; ELECTRODES; FULLERENES; GLASS; HUMANS; OXIDATION-REDUCTION; TABLETS; TIME FACTORS;

EID: 84863743707     PISSN: 15675394     EISSN: 1878562X     Source Type: Journal    
DOI: 10.1016/j.bioelechem.2012.06.004     Document Type: Article

References (44)

1. Clercq D.E. Antiviral drugs: current state of the art. J. Clin. Virol. 2001, 22:73-89.
2. Brien J.J.O., Campoli-Richards D.M. Acyclovir: an updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1989, 37:233-309.
3. Visor G.C., Jackson S.E., Kenley R.A., Lee G.C. Electrochemistry of purine derivatives 1: direct determination for the antiviral drug 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine by anodic differential pulse voltammetry. J. Pharm. Sci. 1985, 74:1078-1081.
4. Oliveira-Brett A.M., Matysik F.M. Voltammetric and sonovoltammetric studies on the oxidation of cytosine and thymine at a glassy carbon electrode. J. Electroanal. Chem. 1997, 429:95-99.
5. Mascher H., Kikuta C., Metz R., Vergin H. New, high-sensitivity high-performance liquid chromatographic method for the determination of acyclovir in human plasma, using fluorometric detection. J. Chromatogr. 1992, 583:122-127.
6. Boulieu R., Gallant C., Silberstein N. Determination of acyclovir in human plasma by high-performance liquid chromatography. J. Chromatogr. B 1997, 693:233-236.
7. Swart K.J., Hundt H.K.L., Groenewald A.M. Automated high-performance liquid chromatographic method for the determination of acyclovir in plasma. J. Chromatogr. A 1994, 663:65-69.
8. Smith R.L., Walker D.D. High-performance liquid chromatographic determination of acyclovir in serum. J. Chromatogr. 1985, 343:203-207.
9. Tadepalli S.M., Quinn R.P., Averett D.R. A competitive enzyme-linked immunosorbent assay to quantitate acyclovir and BW B759U in human plasma and urine. Antimicrob. Agents Chemother. 1986, 29:93-98.
10. Skubitz K.M., Quinn R.P., Lietman P.S. Rapid acyclovir radioimmunoassay, using charcoal adsorption. Antimicrob. Agents Chemother. 1982, 21:352-354.
11. Mustafa A.A., Abdel-Fattah S.A., Toubar S.S., Sultan M.M. Spectrophotometric determination of acyclovir and amantadine hydrochloride through metals complexation. J. Anal. Chem. 2004, 59:40-45.
12. Ayad M.M., Abdellatef H.E., El-Henawee M.M., El-Sayed H.M. Spectrophotometric and spectrofluorimetric methods for analysis of acyclovir and acebutolol hydrochloride. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2007, 66:106-110.
13. Wang F., Chen L., Chen X., Hu S. Studies on electrochemical behaviors of acyclovir and its voltammetric determination with nano-structured film electrode. Anal. Chim. Acta 2006, 576:17-22.
14. Page T., Sherwood C., Connor J.D., Tarnowski T. Simple reversed-phase high-performance liquid chromatography quantitation of ganciclovir in human serum and urine. J. Chromatogr. B Biomed. Appl. 1996, 675:342-346.
15. Asberg A., Hansen C.N., Reubsaet L. Determination of ganciclovir in different matrices from solid organ transplanted patients treated with a wide range of concomitant drugs. J. Pharm. Biomed. Anal. 2007, 43:1039-1044.
16. Chu F., Kiang C.H., Sung M.L., Huang B., Reeve R.L., Tarnowski T. A rapid, sensitive HPLC method for the determination of ganciclovir in human plasma and serum. J. Pharm. Biomed. Anal. 1999, 21:657-667.
17. Campanero M.A., Sadaba B., Garcia-Quetglas E., Azanza J.R. Development and validation of a sensitive method for the determination of ganciclovir in human plasma samples by reversed-phase high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 1998, 706:311-317.
18. Merodio M., Campanero M.A., Mirshahi T., Mirshahi M., Irache J.M. Development of a sensitive method for the determination of ganciclovir by reversed-phase high-performance liquid chromatography. J. Chromatogr. A 2000, 870:159-167.
19. Tsuchie M., Hara S., Kimura M., Fujii M., Ono N., Kai M. Determination of anti-virus drug, ganciclovir, in human serum by HPLC with precolumn fluorescence derivatization using phenylglyoxal. Anal. Sci. 2001, 17:811-814.
20. Boulieu R., Bleyzac N., Ferry S. High-performance liquid chromatographic determination of ganciclovir in plasma. J. Chromatogr. 1991, 567:480-484.
21. Schenkel F., Rudaz S., Daali Y., Oestreicher M.K., Veuthey J.L., Dayer P. Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005, 826:1-7.
22. Lee H.W., Seo J.H., Lee K.T. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry for the determination of penciclovir in human plasma: application to a bioequivalence study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 852:382-388.
23. Hsu L.C., Constable D.J., Orvos D.R., Hannah R.E. Comparison of high-performance liquid chromatography and capillary zone electrophoresis in penciclovir biodegradation kinetic studies. J. Chromatogr. B Biomed. Appl. 1995, 669:85-92.
24. Perrottet N., Beguin A., Meylan P., Pascual M., Manuel O., Buclin T., Biollaz J., Decosterd L.A. Determination of aciclovir and ganciclovir in human plasma by liquid chromatography-spectrofluorimetric detection and stability studies in blood samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 852:420-429.
25. McMullin C.M., Kirk B., Sunderland J., White L.O., Reeves D.S., MacGowan A.P. A simple high performance liquid chromatography (HPLC) assay for aciclovir and ganciclovir in serum. J. Antimicrob. Chemother. 1996, 38:739-740.
26. Teshima D., Otsubo K., Yoshida T., Itoh Y., Oishi R. A simple and simultaneous determination of acyclovir and ganciclovir in human plasma by high-performance liquid chromatography. Biomed. Chromatogr. 2003, 17:500-503.
27. Pham-Huy C., Stathoulopoulou F., Sandouk P., Scherrmann J.M., Palombo S., Girre C. Rapid determination of valaciclovir and acyclovir in human biological fluids by high-performance liquid chromatography using isocratic elution. J. Chromatogr. B Biomed. Sci. Appl. 1999, 732:47-53.
28. Xu H.R., Li X.N., Chen W.L., Liu G.Y., Chu N.N., Yu C. A sensitive assay for simultaneous determination of plasma concentrations of valganciclovir and its active metabolite ganciclovir by LC/MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 848:329-334.
29. Wutzler P., Thust R. Genetic risks of antiviral nucleoside analogues - a survey. Antiviral. Res. 2001, 49:55-74.
30. 60-modified carbon electrode. Anal. Chim. Acta 2003, 491:181-191.
31. 60-modified electrode as a sensitive voltammetric sensor for detection of nandrolone-An anabolic steroid used in doping. Anal. Chim. Acta 2007, 597:82-89.
32. Szucs A., Tolgyesi M., Csiszar M., Nagy J.B., Novak M. Electrochemistry on partially reduced fullerene films. Electrochim. Acta 1998, 44:613-621.
33. Csiszar M., Szues A., Tolgyesi M., Mechler A., Nagy J.B., Novak M. Electrochemical reactions of cytochrome c on electrodes modified by fullerene films. J. Electroanal. Chem. 2001, 497:69-74.
34. Goyal R.N., Bachheti N., Tyagi A., Pandey A.K. Differential pulse voltammetric determination of methylprednisolone in pharmaceuticals and human biological fluids. Anal. Chim. Acta 2007, 605:34-40.
35. Szues A., Loix A., Nagy J.B., Lamberts L. Fullerene film electrodes in aqueous solutions Part 1. Preparation and electrochemical characterization. J. Electroanal. Chem. 1995, 397:191-203.
36. Gosser D.K. Cyclic Voltammetry: Simulations and Analysis of Reaction Mechanisms 1993, 43. VCH, New York.
37. Bard A.J., Faulkner L.R. Electrochemical Methods: Fundamentals and Applications 2004, 594. Wiley, New York. 2nd ed.
38. Yunhua W., Xiaobo J., Shengshui H. Studies on electrochemical oxidation of azithromycin and its interaction with bovine serum albumin. Bioelectrochemistry 2004, 64:91-97.
39. Goyal R.N., Dhawan A. Electrochemical oxidation of inosine 5'-monophosphate in neutral aqueous solution. Electroanal. Chem. 2006, 591:159-167.
40. Oliveira-Brett A.M., Diculescn V., Piedade J.A.P. Electrochemical oxidation mechanism of guanine and adenine using a glassy carbon microelectrode. Bioelectrochemistry 2002, 55:61-62.
41. Wang H.S., Ju H.X., Chen H.Y. Simultaneous determination of guanine and adenine in DNA using an electrochemically pretreated glassy carbon electrode. Anal. Chim. Acta 2002, 461:243-250.
42. Heli H., Zarghan M., Jabbari A., Parsaei A., Moosavi-Movahedi A.A. Electrocatalytic oxidation of the antiviral drug acyclovir on a copper nanoparticles-modified carbon paste electrode. J. Solid State Electrochem. 2010, 14:787-795.
43. Peh K.-K., Yuen K.-H. Simple high-performance liquid chromatographic method for the determination of acyclovir in human plasma using fluorescence detection. J. Chromatogr. B 1997, 693:241-244.
44. Jankowski A., Jankowska A.L., Lamparczyk H. Determination and pharmacokinetics of acyclovir after ingestion of suspension form. J. Pharm. Biomed. Anal. 1998, 18:249-254.